Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant Barrett's oesophagus

H Li1

  • 1Department of Surgery, Beijing Red Cross Chaoyang Hospital, China.

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ.

The Journal of biological chemistry·1996
Same author

Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha.

The Journal of biological chemistry·1996
Same author

Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.

Cancer research·1996
Same author

Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box.

Oncogene·1996
Same author

Emergence of preferred structures in a simple model of protein folding.

Science (New York, N.Y.)·1996
Same author

Developmental regulation of collagen differential expression in the rabbit bladder.

The Journal of urology·1996
Same journal

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Risk of pancreatic cancer in patients with vitamin D deficiency: a retrospective cohort study.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Recommendations for the use of CanRisk for tubo-ovarian cancer risk estimation: a focus group and Research ANd Development-modified Delphi-based study.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Sociodemographic factors predicting preference for human papillomavirus self-sampling in cervical cancer screening: comparison of opt-out and opt-in strategies.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

The European Cancer Prevention Organization celebrates 45 years of advancing progress in cancer prevention.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Effectiveness of palliative care in managing adverse reactions in cancer patients: a systematic review and meta-analysis.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
See all related articles

Barrett's oesophagus is a pre-malignant condition increasing adenocarcinoma risk. Early detection via dysplasia monitoring and surgical resection improves dismal prognoses for this condition.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Pathology

Background:

  • Barrett's oesophagus is a pre-malignant condition associated with a significantly increased risk of oesophageal adenocarcinoma.
  • While adenocarcinoma prevalence in Barrett's oesophagus is approximately 10%, its overall incidence in the general population remains undetermined.
  • The progression to adenocarcinoma is a multi-step process, often occurring without typical gastro-oesophageal reflux symptoms, and diagnosis is frequently simultaneous with carcinoma detection.

Purpose of the Study:

  • To review the current understanding of Barrett's oesophagus and its progression to adenocarcinoma.
  • To discuss diagnostic and management strategies, including surgical interventions and surveillance protocols.
  • To highlight the prognostic factors and recent advancements in treating Barrett's carcinoma.

Related Experiment Videos

Main Methods:

  • Literature review of Barrett's oesophagus, adenocarcinoma development, and treatment outcomes.
  • Analysis of diagnostic indicators, focusing on dysplasia as a marker for malignancy.
  • Evaluation of surgical management, specifically three-stage oesophagectomy, and prognostic data.

Main Results:

  • Adenocarcinoma in Barrett's oesophagus carries a dismal prognosis, strongly correlated with tumour stage.
  • Surgical resection, particularly three-stage oesophagectomy, is the primary treatment for identified carcinoma.
  • Recent years have shown encouraging outcomes, suggesting improved management strategies.

Conclusions:

  • Dysplasia is currently the most reliable indicator of malignancy in Barrett's oesophagus.
  • While endoscopic surveillance remains debated, it is recommended for specific high-risk patient groups.
  • Despite challenges, advancements in treatment offer hope for improved survival rates in Barrett's carcinoma.